REAL-WORLD NON-PERSISTENCE WITH ORAL MULTIPLE MYELOMA TREATMENTS: A COMPARATIVE ANALYSIS OF METHODOLOGIES USING CLAIMS DATA

被引：0
|
作者：
Kocaata, Z. [1 ]
Mueller, S. [2 ]
Maywald, U. [3 ]
Wilke, T. [4 ]
机构：
[1] Ingress Hlth HWM GmbH, Wismar, MV, Germany
[2] Ingress Hlth, Wismar, Germany
[3] AOK PLUS, Dresden, Germany
[4] IPAM eV, Wismar, Germany
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN156
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [41] Epidemiology of AL amyloidosis: a real-world study using US claims data
    Quock, Tiffany P.
    Yan, Tingjian
    Chang, Eunice
    Guthrie, Spencer
    Broder, Michael S.
    BLOOD ADVANCES, 2018, 2 (10) : 1046 - 1053
  • [42] Immunomodulatory drugs increase the risk of serious infections in multiple myeloma patients: A meta-analysis using real-world data
    Hussain, M. S.
    Zeba, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 278 - 278
  • [43] Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data
    Dodick, David W.
    Shewale, Anand S.
    Lipton, Richard B.
    Baum, Seth J.
    Marcus, Steven C.
    Silberstein, Stephen D.
    Pavlovic, Jelena M.
    Bennett, Nathan L.
    Young, William B.
    Viswanathan, Hema N.
    Doshi, Jalpa A.
    Weintraub, Howard
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [44] How Common is Essential Tremor in Germany? A Real-World Claims Data Analysis
    Becktepe, J. S.
    Mueller, S.
    Wilke, T.
    Zhuleku, E.
    Appiah, K.
    McDonald, K.
    Dzimitrowicz, N.
    Marshall, J.
    Sabater, J.
    Barbato, L. M.
    Saifee, T. A.
    MOVEMENT DISORDERS, 2024, 39 : S710 - S710
  • [45] How Common is Essential Tremor in Germany? A Real-World Claims Data Analysis
    Becktepe, J. S.
    Mueller, S.
    Wilke, T.
    Zhuleku, E.
    Appiah, K.
    McDonald, K.
    Dzimitrowicz, N.
    Marshall, J.
    Sabater, J.
    Barbato, L. M.
    Saifee, T. A.
    MOVEMENT DISORDERS, 2024, 39 : S710 - S710
  • [46] Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany
    Emily Holthuis
    Elisabeth Smits
    George Spentzouris
    Dominik Beier
    Dirk Enders
    Rosa Gini
    Claudia Bartolini
    Giampiero Mazzaglia
    Fernie Penning-van Beest
    Ron Herings
    Drugs - Real World Outcomes, 2022, 9 : 597 - 607
  • [47] A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting
    Rifkin, Robert M.
    Medhekar, Rohan
    Amirian, E. Susan
    Aguilar, Kathleen M.
    Wilson, Thomas
    Boyd, Marley
    Mezzi, Khalid
    Panjabi, Sumeet
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 10
  • [48] A Real-World Comparative Analysis of Carfilzomib and Other Systemic Multiple Myeloma Chemotherapies in the US Community Oncology Setting
    Rifkin, Robert M.
    Medhekar, Rohan
    Amirian, E. Susan
    Wilson, Thomas
    Boyd, Marley
    Mezzi, Khalid
    Panjabi, Sumeet
    BLOOD, 2017, 130
  • [49] Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
    Sruamsiri, Rosarin
    Iwasaki, Kosuke
    Tang, Wentao
    Mahlich, Joerg
    BMC DERMATOLOGY, 2018, 18
  • [50] Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis
    Fiehn, Christoph
    Zinke, Silke
    Haas, Jennifer S.
    Meise, Dominic
    Theil, Julia
    Gurrath, Margot
    Orzechowski, Hans-Dieter
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (09): : 739 - 753
12345